Tetracyclines at subinhibitory concentrations are lethal for NADH peroxidase-deficient mutants of Enterococcus

Valentin Wasselin1, Aurélie Budin-Verneuil1, Isabelle Rincé1

  • 1CBSA UR 4312, Université de Caen Normandie, Univ Rouen Normandie, Normandie Univ, Caen F-14 000, France.

Abstract

Insights

Vancomycin-resistant Enterococcus faecium (VR-Efm) antibiotic resistance can be overcome by targeting oxidative stress defenses. Impairing hydrogen peroxide (H2O2) detoxification potentiates tigecycline efficacy against these difficult-to-treat infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Tigecycline is a critical last-line antibiotic for treating infections caused by multidrug-resistant (MDR) pathogens, including vancomycin-resistant Enterococcus faecium (VR-Efm).
  • Oxidative stress plays a role in bacterial physiology and antibiotic resistance mechanisms.
  • Understanding the interplay between oxidative stress and antibiotic efficacy is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the role of oxidative stress defense mechanisms in VR-Efm's resistance to tigecycline.
  • To determine if targeting specific oxidative stress pathways can re-sensitize VR-Efm to tigecycline.

Main Methods:

  • Evaluated antibiotic susceptibility of VR-Efm mutants lacking key oxidative stress defense proteins.
  • Quantified intracellular hydrogen peroxide (H2O2) levels in bacterial mutants.
  • Assessed the contribution of different enzymes (NADH peroxidase, lactate oxidase, pyruvate oxidase) to H2O2 metabolism.

Main Results:

  • Mutants deficient in NADH peroxidase (Npr) exhibited unexpected lethality when exposed to sub-inhibitory concentrations of tigecycline and other tetracyclines.
  • This tigecycline lethality correlated with increased intracellular H2O2 accumulation in the Δnpr mutant.
  • Lactate oxidase (Lox1) was identified as the primary enzyme responsible for H2O2 production in VR-Efm, with minor contributions from Lox2 and pyruvate oxidase (Pox).
  • A ΔnprΔlox1 double mutant was not killed by tigecycline, indicating that the combined effect of the antibiotic and peroxide accumulation drives lethality.

Conclusions:

  • Targeting NADH peroxidase and modulating hydrogen peroxide levels represent a potential strategy to enhance tigecycline's effectiveness against VR-Efm.
  • Increasing endogenous H2O2 production or impairing its detoxification could improve treatment outcomes for infections caused by this challenging pathogen.
  • This research opens avenues for novel therapeutic approaches to combat antibiotic resistance.